| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000018410 |
| Receipt No. | R000021316 |
| Official scientific title of the study | Test of the energy metabolism-promoting effect of lactic acid bacteria beverage |
| Date of disclosure of the study information | 2015/07/27 |
| Last modified on | 2016/07/20 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Test of the energy metabolism-promoting effect of lactic acid bacteria beverage | |
| Title of the study (Brief title) | Test of the energy metabolism-promoting effect of lactic acid bacteria beverage | |
| Region |
|
|
| Condition | ||
| Condition | Obesity | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the energy metabolism-promoting efficacy and safety of lactic acid bacteria beverage |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | energy metabolism |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | lactic acid bacteria beverage | |
| Interventions/Control_2 | lactic acid bacteria-free beverage | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Males and females aged 20 to less than 65 years old.
2) 25 kg/m2 <= BMI < 30 kg/m2. |
|||
| Key exclusion criteria | 1) Subjects who regularly take part in exercise and/or sports (except taking a walk) or do muscle training three times and more a week.
2) Subjects who are on a diet. 3) Subjects who have the habit of taking foods containing a high number of lactic acid bacteria (fermented milk drink, yoghurt, kimuchi, and so on) and/or lactic acid bacteria preparations three times and more a week. 4) Subjects who constantly use supplements and/or functional foods (including Food for Specified Health Uses) affecting the body fat and/or fat metabolism, or who constantly use medicines and/or functional foods affecting the test results. 5) Subjects who take continuous medical treatment. 6) Subjects who have allergic reaction to food. 7) Subjects who drink alcohol a lot (20 g and more of alcohol a day on average) and/or smoke a lot (21 and more cigarettes a day on average) 8) Subjects who have an extremely irregular diet habit or alternative work schedule or work on midnight shift 9) Subjects who are judged as unsuitable for the study by the principal investigator for other reasons. |
|||
| Target sample size | 64 | |||
| Research contact person | |
| Name of lead principal investigator | Junichi Nakamura |
| Organization | Suntory Global Innovation Center Limited |
| Division name | Research Institute |
| Address | 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto |
| TEL | 050-3182-0460 |
| Junichi_Nakamura@suntory.co.jp | |
| Public contact | |
| Name of contact person | Eiji Fukushima |
| Organization | Suntory Global Innovation Center Limited |
| Division name | Research Institute |
| Address | 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto |
| TEL | 050-3182-0544 |
| Homepage URL | |
| Eiji_Fukushima@suntory.co.jp | |
| Sponsor | |
| Institute | TTC Co.,Ltd. |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Suntory Beverage & Food Limited |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021316 |